TGF-β signaling in myeloid cells promotes CCL2-dependent MDSC recruitment to the tumor microenvironment, and granulocytic MDSC-derived TGF-β promotes EMT upon metastasis, which is the advanced form of malignancy (139, 140). Here, TGFB1 is linked to neoplasm.